Track Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s other current assets ($1.3T) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), RVPHW shows a other current assets of $1.3T. That compares with $450K in the prior-year period — up 277048975.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, RVPHW's other current assets is now $1.3T (was $450K) — a 277048975.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is outperforming or lagging.
Tracking RVPHW's other current assets over time shows whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3T That compares with $450K in the prior-year period — up 277048975.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current assets page, Stockcircle has Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.3T) with ownership activity and broader fundamentals.
Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s other current assets is $1.3T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.